These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 14159482)

  • 1. FIBRINOLYTIC THERAPY IN MENINGITIS AND VENTRICULITIS.
    STEWART GT
    J Clin Pathol; 1964 May; 17(3):355-9. PubMed ID: 14159482
    [No Abstract]   [Full Text] [Related]  

  • 2. THE USE OF FIBRINOLYTIC ACTIVATORS IN MENINGITIS AND SIMILAR CONDITIONS.
    NEWMAN RL; STEWART GT
    Arch Dis Child; 1965 Jun; 40(211):235-42. PubMed ID: 14294748
    [No Abstract]   [Full Text] [Related]  

  • 3. THE PROACTIVATOR (PLASMINOGEN?) DETERMINATION IN PLASMA DURING FIBRINOLYTIC THERAPY.
    BLIX S
    Acta Med Scand; 1964 Nov; 176():649-50. PubMed ID: 14223542
    [No Abstract]   [Full Text] [Related]  

  • 4. [THROMBOLYTIC THERAPY AND CHANGES IN FIBRINOLYTIC ACTIVITY].
    DOUGLAS AS; MCNICOL GP
    Recenti Prog Med; 1964 Sep; 37():189-217. PubMed ID: 14229145
    [No Abstract]   [Full Text] [Related]  

  • 5. CURRENT STATUS OF THROMBOLYTIC THERAPY.
    SHERRY S
    Geriatrics; 1964 Sep; 19():628-43. PubMed ID: 14221883
    [No Abstract]   [Full Text] [Related]  

  • 6. THROMBOLYTIC THERAPY.
    DOUGLAS AS; MCNICOL GP
    Br Med Bull; 1964 Sep; 20():228-32. PubMed ID: 14209763
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of epsilon-amino-caproic acid on prolactin-inactivating and fibrinolytic activities of streptokinase-activated plasminogen.
    HOPKINS TF; MEITES J
    Proc Soc Exp Biol Med; 1963 Apr; 112():830-2. PubMed ID: 13961684
    [No Abstract]   [Full Text] [Related]  

  • 8. [ON A METHOD FOR THE DETERMINATION OF PLASMA FIBRINOLYTIC ACTIVITY].
    SHIRAI T
    Klin Wochenschr; 1964 Jun; 42():586-8. PubMed ID: 14236987
    [No Abstract]   [Full Text] [Related]  

  • 9. PRACTICAL METHOD FOR THROMBOLYTIC THERAPY WITH STREPTOKINASE. MAINTENANCE OF NEARLY COMPLETE PLASMINOGEN DEPLETION ASSOCIATED WITH HIGH CIRCULATING ACTIVATOR ACTIVITY.
    VERSTRAETE M; AMERY A; VERMYLEN J; VERMYLEN C; DEVREKER R
    Br Med J; 1964 Mar; 1(5384):675-6. PubMed ID: 14096464
    [No Abstract]   [Full Text] [Related]  

  • 10. FIBRINOLYTIC THERAPY OF THROMBOEMBOLIC DISEASE.
    COON WW; PENNER JA
    Surg Gynecol Obstet; 1964 Sep; 119():495-502. PubMed ID: 14210147
    [No Abstract]   [Full Text] [Related]  

  • 11. THROMBOLYTIC THERAPY.
    FLUTE PT
    J Clin Pathol; 1964 May; 17(3):333-5. PubMed ID: 14159475
    [No Abstract]   [Full Text] [Related]  

  • 12. FIBRINOLYTIC AND ESTEROLYTIC ACTIVITY OF HUMAN PLASMA.
    ADAMIS DM; MANIATIS GM
    Thromb Diath Haemorrh; 1965 Jun; 13():484-91. PubMed ID: 14347870
    [No Abstract]   [Full Text] [Related]  

  • 13. THE LABORATORY CONTROL OF THROMBOLYTIC THERAPY.
    HAWKEY C; HOWELL M
    J Clin Pathol; 1964 May; 17(3):287-91. PubMed ID: 14159462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. THROMBOLYTIC THERAPY.
    DOUGLAS AS; MCNICOL GP
    Proc R Soc Med; 1964 Jul; 57(7):609-14. PubMed ID: 14178954
    [No Abstract]   [Full Text] [Related]  

  • 15. [Streptokinase and fibrinolytic processes].
    CHASSAGNE P; BLONDET P; HENNEQUET A
    Therapie; 1952; 7(3):231-5. PubMed ID: 14950815
    [No Abstract]   [Full Text] [Related]  

  • 16. THROMBOLYTIC THERAPY.
    MCNICOL GP; DOUGLAS AS
    J Clin Pathol; 1964 May; 17(3):338-40. PubMed ID: 14159477
    [No Abstract]   [Full Text] [Related]  

  • 17. FIBRINOLYTIC THERAPY OF THROMBOPHLEBITIS. TWENTY-FIVE CASES STUDIED WITH SERIAL VENOGRAMS.
    HECKER SP
    Calif Med; 1964 Jul; 101(1):23-9. PubMed ID: 14179527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PLASMINOGEN AS A USEFUL PARAMETER IN THROMBOLYTIC THERAPY.
    DEVREKER R
    Sangre (Barc); 1964; 41():452-4. PubMed ID: 14248834
    [No Abstract]   [Full Text] [Related]  

  • 19. Fibrinolytic therapy of coronary thrombosis. Controlled trial of 75 cases.
    DEWAR HA; STEPHENSON P; HORLER AR; CASSELLS-SMITH AJ; ELLIS PA
    Br Med J; 1963 Apr; 1(5335):915-20. PubMed ID: 14027424
    [No Abstract]   [Full Text] [Related]  

  • 20. Assay of thrombolytic ('fibrinolytic') mixtures intended for therapeutic use.
    FLETCHER AP; ALKJAERSIG N; SHERRY S
    J Lab Clin Med; 1961 Apr; 57():620-9. PubMed ID: 13700257
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.